Research News and Research

RSS

Dutch study shows off-label targeted therapies benefit more cancer patients

The largest published prospective evaluation of off-label targeted cancer therapies has shown that more patients could benefit from existing drugs.

15 Apr 2026

AP-1 proteins help cancer cells rewire genes to survive treatment

A long-standing mystery in cancer treatment is how tumor cells so often become resistant to drugs, even ones they have never encountered before.

15 Apr 2026

Brain organoids reveal mutation-specific insights for Rett syndrome

Though many studies approach the developmental disorder Rett syndrome as a single condition arising from general loss of function in the gene MECP2, a new study by neuroscientists in The Picower Institute for Learning and Memory at MIT shows that two different mutations of the gene caused many distinct abnormalities in lab cultures.

15 Apr 2026

Calorie labels on menus may benefit people with binge eating disorders

Food calorie labels on menus in cafes and restaurants can be helpful for people with binge eating disorders, even aiding their recovery, finds new research from UCL and King's College London.

15 Apr 2026

Brief intense workouts offer significant health benefits

At this time of year, many people make an extra effort to establish good exercise routines. We know that exercise is good for our health, but it can still be difficult to get started and maintain good habits.

15 Apr 2026

Registry data and AI can identify high risk populations for skin cancer

Healthcare registry data can show early risk patterns for melanoma skin cancer, according to a study from the University of Gothenburg.

15 Apr 2026

New biochip detects tiny genetic markers in 20 minutes

A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has developed a new biochip that, when paired with Artificial Intelligence (AI), can detect quickly and accurately extremely small amounts of microRNAs, which are tiny genetic markers linked to diseases such as heart disease.

15 Apr 2026

Breakthrough blood test predicts kidney failure years before clinical symptoms

A new blood test can identify which individuals of African ancestry carrying high-risk APOL1 gene variants are most likely to develop kidney failure, years before clinical disease becomes apparent.

15 Apr 2026

Loneliness is linked to higher risk of degenerative heart valve disease

Adults who reported feeling lonely had a higher risk of developing degenerative heart valve disease, even after accounting for traditional heart disease risk factors and genetics, according to new research published today in the Journal of the American Heart Association, an open-access, peer-reviewed journal of the American Heart Association.

15 Apr 2026

Northwestern engineers create artificial neurons that communicate with living cells

Northwestern University engineers printed artificial neurons that don't just imitate the brain - they talk to it.

15 Apr 2026

Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East

Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has established a strategic partnership with JH Health Ltd, a Saudi Arabian company focused on medical and health-related technology.

From Atelerix Ltd 15 Apr 2026

“Natural” and “healthy” labels may confuse shoppers more than help

Study reveals that front-of-pack labels alone can't ensure healthy choices, as perceptions of naturalness and processing shape consumer behavior.

15 Apr 2026

Medi-Cal immigrant enrollment is dropping. Researchers point to Trump’s policies.

For months, a cloud of fear has hovered over the immigrant community in San Bernardino, California, making it hard for María González to do her job as a community health worker in this city where almost a quarter of residents are foreign-born.

15 Apr 2026

Gaining weight before age 30 tied to higher mortality

The study reveals that weight gain before 30 years is associated with increased mortality risk, underscoring the need for early obesity intervention strategies.

15 Apr 2026

Rural Nebraska dialysis unit closes despite the state’s $219M in rural health funding

The sun was just warming the horizon as Mark Pieper left his house near his cattle ranch on a crisp February morning.

15 Apr 2026

ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discovery

ORGAPRED, a France-based core facility specializing in Patient-Derived Tumor Organoid (PDTO) research, has selected the CYTOQUBE high-throughput 3D imaging system from Hamamatsu Photonics France to support personalized oncology drug screening and therapeutic discovery.

From Hamamatsu Photonics Europe 15 Apr 2026

Bio-Rad extends range of anti-idiotypic antibodies and anti-Fc mutation antibodies for bioanalysis and drug monitoring

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today extended its range of recombinant monoclonal anti-idiotypic antibodies, with the introduction of eight antibodies specific to romosuzumab (Evenity), burosumab (Crysvita), ixekizumab (Taltz), elotuzumab (Empliciti), isatuximab (Sarclisa), nirsevimab (Beyfortus), and tremelimumab (Imjudo), and released a recombinant monoclonal anti-biotherapeutic antibody specific to dulaglutide (Trulicity).

From Bio-Rad Laboratories 15 Apr 2026

SPT Labtech and EMBL GeneCore collaborate to advance fully walkaway automation in genomics workflows

SPT Labtech, a global leader in the design and development of laboratory automation and liquid handling solutions, and the European Molecular Biology Laboratory's Genomics Core Facility (EMBL GeneCore), today announced a collaboration to advance fully walkaway automated genomics workflows.

From SPT Labtech 15 Apr 2026

ProImmune collaborates with The University of Texas Medical Branch to advance infectious disease research

ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools for studying high-consequence emerging and endemic infectious diseases.

From ProImmune Ltd. 15 Apr 2026

VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

VALANX Biotech (VALANX), a biotech company developing novel technology for site-specific protein conjugation in drug discovery, today announced the formation of its Scientific Advisory Board (SAB), appointing John Lambert as Chair, with Morris Rosenberg and Peter de Waele serving alongside.

From VALANX Biotech 15 Apr 2026

Research News and Research

Dutch study shows off-label targeted therapies benefit more cancer patients

AP-1 proteins help cancer cells rewire genes to survive treatment

Brain organoids reveal mutation-specific insights for Rett syndrome

Calorie labels on menus may benefit people with binge eating disorders

Brief intense workouts offer significant health benefits

Registry data and AI can identify high risk populations for skin cancer

New biochip detects tiny genetic markers in 20 minutes

Breakthrough blood test predicts kidney failure years before clinical symptoms

Loneliness is linked to higher risk of degenerative heart valve disease

Northwestern engineers create artificial neurons that communicate with living cells

Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East

“Natural” and “healthy” labels may confuse shoppers more than help

Medi-Cal immigrant enrollment is dropping. Researchers point to Trump’s policies.

Gaining weight before age 30 tied to higher mortality

Rural Nebraska dialysis unit closes despite the state’s $219M in rural health funding

ORGAPRED selects CYTOQUBE® from Hamamatsu Photonics for personalized oncology research and therapeutic discovery

Bio-Rad extends range of anti-idiotypic antibodies and anti-Fc mutation antibodies for bioanalysis and drug monitoring

SPT Labtech and EMBL GeneCore collaborate to advance fully walkaway automation in genomics workflows

ProImmune collaborates with The University of Texas Medical Branch to advance infectious disease research

VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo